PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

UK rolls out Moderna’s COVID vaccine

The UK rollout of Moderna's coronavirus vaccine has begun today in Wales, following its approval back in January. The government has ordered 17 million doses of the ...
Continue Reading →
News

Artios, Novartis form cancer therapies collaboration

Artios Pharma and Novartis have formed a global research collaboration to discover and validate next generation DNA damage response (DDR) targets to enhance the Swis...
Continue Reading →
News

Twice weekly rapid COVID-19 testing to be available to everyone in England

Access to twice weekly, free, regular, rapid coronavirus (COVID-19) testing from 9 April for everyone in England, the Government has announced. Everyone in Engla...
Continue Reading →
News

Oxford COVID vaccine team wins funding to develop jab to prevent gonorrhea

The Jenner Institute, part of the University of Oxford, UK, has been awarded up to US$2 million to develop a novel vaccine to prevent gonorrhea, the sexually-transmi...
Continue Reading →
News

Aptar Pharma and RDD Online Partner to Present Reimagined RDD 2021 Virtual Conference, Live Events May 4-7, 2021

Aptar Pharma, leader in respiratory drug delivery solutions and RDD Online®, organizers of Respiratory Drug Delivery (RDD®) conferences, are pleased to announce thei...
Continue Reading →
News

Inctye’s Pemazyre authorised in the EU for bile duct cancer

The European Commission (EC) has approved Incyte’s kinase inhibitor Pemazyre for the treatment of certain patients with advanced cholangiocarcinoma, also known as bi...
Continue Reading →
News

FDA green light for BMS, bluebird bio’s CAR-T therapy Abecma in multiple myeloma

Bristol Myers Squibb (BMS) and bluebird bio have received US Food and Drug Administration (FDA) approval for their CAR-T therapy Abecma in multiple myeloma. Abecma (...
Continue Reading →
News

EU approval for new AI technology that can predict heart attacks

New artificial intelligence (AI) technology that can identify if people are at high risk of having a fatal heart attack before it occurs has been approved in the EU....
Continue Reading →
News

New lateral flow device distribution service announced for pharmacies

A new advanced service – the NHS community pharmacy COVID-19 lateral flow device distribution service – has been added to the NHS Community Pharm...
Continue Reading →
News

Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna

EMA's human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026